A 75-year-old man presented to his physician with weakness, anorexia, and constant right upper quadrant pain. He underwent a laparoscopic cholecystectomy, which was converted to an open cholecystectomy due to presumed adhesions. Direct examination of the liver was negative for masses or lesions. A CT scan was negative for masses or nodules. The gallbladder was 8.5 Â 2.5 cm 2 , with a diffusely thick wall measuring 2.5 cm. Microscopic examination showed a monomorphic tumor consisting of cells with increased nuclear:cytoplasmic ratio and occasional nucleoli, infiltrating the entire gallbladder uniformly. The tumor cells that reacted to antibodies directed against HepPar1, CAM 5.2, CK19 and scattered cells were immunoreactive for CD117, CD34, and CD56. This immunohistochemical profile suggested a 'hepatocellular progenitor cell tumor of the gall bladder'. This report is, to our knowledge, the first such case of a tumor of this cell type reported in the gallbladder. In addition, we present a review of the literature.
Primary malignant tumors of the gallbladder are predominantly adenocarcinomas; rarely, lymphoma or sarcoma occur. We recently studied a malignant tumor restricted to the gallbladder with light microscopic and immunohistochemical characteristics of hepatic progenitor cells.
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Case report
A 75-year-old Caucasian man presented to his physician with weakness, anorexia, and constant right upper quadrant pain. Past medical history was significant for hypertension, type II diabetes mellitus, and remote appendectomy. He had a remote two packs per day smoking history (30 years prior). He was not jaundiced but was dehydrated and febrile (101 0 ). Laboratory tests of comprehensive metabolic profile, including standard liver tests, were within normal limits. He was anemic (hemoglobin 12.4 g/dl, hematocrit 36.4%) and his white blood cell count was increased (10.8 th/mm 3 ). Current medications included glucophage, glyburide, triamterene/ hydrochlorthiazide, lisinopril, and chlordiazepoxide.
Laparoscopic cholecystectomy was attempted, but because of the perception of adhesions, an open cholecystectomy was performed. Intraoperative cholangiogram was negative for gallstones. There were no liver lesions on direct visual examination. Neither perihepatic nor intra-abdominal adenopathy was noted.
There were no nodules or tumors in the thorax, abdomen, or pelvis with computerized tomographic (CT) scan performed on postoperative day 6.
Pathology
Gross Pathology (Figure 1) The gallbladder measured 8.5 Â 2.5 cm 2 ; the wall was diffusely and uniformly thickened to 2.5 cm. A single dark green, 1.5 Â 1.5 Â 1 cm 3 , granular, ovoid stone was present. The mucosa was focally hemorrhagic but was otherwise velvety and without lesions.
Microscopic Pathology (Figure 2)
A monomorphic tumor infiltrated the lamina propria, submucosa, muscularis propria, and serosa.
The surface mucosa was intact and unremarkable, without evidence of dysplasia or in situ carcinoma. The tumor was in sheets and small clusters around vessels, but no evidence of gland or trabecular formation was seen; tumor necrosis was extensive. The tumor cells were round to oval, and showed mild nuclear pleomorphism, increased nuclear: cytoplasmic ratio, margination of chromatin, and occasional prominent nucleoli. Mitoses were rarely noted. Perineural invasion and lymphovascular invasion were seen. Additionally, a dense lymphocytic infiltrate was in the lamina propria, with occasional follicles. The adhesions on the serosal surface were negative for tumor.
Immunohistochemistry ( Figure 3 ) Table 1 lists the markers studied in the case. The initial impression of lymphoma was ruled out by a battery of lymphocyte immunohistochemical markers. Immunostains for polyclonal CEA, HMB45, and S-100 were also nonreactive. Positive markers included pankeratin (450%), CK7 (in a cluster of tumor cells, o1%), HepPar1 (positive in 490%), CK19 (focally positive in 25%), CD117 (scattered tumor cells, o1%), CD34 (scattered tumor cells, o1%), CD56 (scattered tumor cells, o1%), CD10 (o1%), EMA (positive in 50%), and CAM 5.2 (positive in 450%). The surface mucosa was diffusely positive for CK7 and CK19, but there were no single cells positive for CD34, CD117, or CD56 in the epithelium.
Based on the clinical observations and gross findings, the tumor was determined to be a primary gallbladder tumor. Light microscopy and immunohistochemical profile indicated hepatic progenitor cell/intermediate cell origin.
Discussion
Hepatic progenitor cells in the normal human liver are small round epithelial cells that reside in the most proximal branches of the biliary system, the Canal of Hering. 3 These cells have been identified as the precursors of the mature hepatocytic and biliary cells. Activated progenitor cells are present in the diseased and regenerating liver. 1 In rodent studies, these cells have been referred to in a variety of terms, including 'oval cells'. 4, 5 In human tissue, subtypes of progenitor cells reflecting different stages of maturation identified by immunohistochemical markers are known to exist. These have been shown in a variety of liver diseases. The immunohistochemical profiles confirm both biliary and hepatocytic phenotypes: OV-6, CK19, CK7, HepPar 1, albumin, neural cell adhesion marker (NCAM-1)(CD56), and stem cell markers: c-kit (CD117) and CD34. 1, 2, 6 Similar cells have also been identified in rodent pancreas, 7 which is derived embryonically with the liver from a common anlage in the endoderm. After pancreatic injury, oval cells in the pancreas have been shown to differentiate Figure 1 Gross photograph of the gallbladder shows a uniformly thickened wall. into hepatocytes, as determined by expression of genes normally in hepatocytes, including alphafetoprotein, albumin, and alpha-1-antitrypsin.
'Intermediate cells' is the term that has been proposed by Roskams and Theise 1,2 for the epithelial cells with a morphologic and immunophenotype intermediate between hepatocytes and cholangiocytes that are seen in varying numbers in hepatic regenerative responses to toxic, metabolic, and inflammatory damage to the hepatic parenchyma. In contrast to small size and diffuse cytoplasmic reactivity with CK7 of progenitor cells, intermediate cells have submembranous reactivity of CK7 and lesser degree of CK19 reactivity. Intermediate cells are a component of the reparative and regenerative response of the liver termed the 'ductular reaction' and have been documented in a variety of disorders including alcoholic and nonalcoholic fatty liver disease, cholestatic liver disease, chronic hepatitis and submassive necrosis. The subject has been reviewed in two recent manuscripts. 1, 2 Neoplasms of progenitor cell origin have been proven in the chemical hepatocarcinogenesis models in rodents. [8] [9] [10] [11] [12] [13] [14] Several groups have reported cells with progenitor phenotype in humans with benign tumors (liver cell adenomas), and in malignant tumors in children (hepatoblastomas) and adults (hepatocellular carcinoma, cholangiocarcinoma and mixed phenotypes). Table 2 reviews the reported cases. In some reported cases, tumor cells were described as arranged in trabeculae, and surrounded by a delicate fibrous stroma, 15 whereas in others, tumors were arranged in strands with vague gland-like structures. 16 Immunohistochemical reactions demonstrated expression of keratins, Hepatocyte-specific antigen (HepPar 1), albumin mRNA, biliary markers (CK7, CK19), stem cell markers (CK14, CD117, CD34) and a neural marker, NCAM (CD56). Ultrastructural examination has also shown features of both hepatocyte and cholangiocyte differentiation. 15 It has been postulated that these tumors arise from progenitor cells with a dual phenotype. 17 Studies of hepatoblastoma have shown varying results. Ruck et al 18 showed ultrastructural characteristics of small epithelial cells, which expressed albumin, a hepatocytic marker, and CK7, a marker of biliary differentiation. OV-1 and OV-6, rodent markers of oval cells, were also positive in fetal and embryonal areas. Conversely, Badve et al their study of 29 tumors, they demonstrated that survival rates for intermediate carcinomas (75%) were between that of hepatocellular carcinomas (62.5%) and transitional combined hepatocellular and cholangiocarcinoma (80%) with follow-up ranging from 14 to 18 months.
Our case is a primary tumor of the gallbladder. As a result of lack of gland formation or trabecular structures and the relatively monomorphic appearance of the tumor cells, we initially suspected lymphoma, or, less likely, melanoma. However, the markers for lymphoma and melanoma were negative and immunohistochemical marker positivity for HepPar 1, CK19, and CD117 led to a diagnosis of a tumor of hepatic progenitor cell/intermediate cell phenotype. The paucity of cells reactive for CK7, CD117, CD56, and CD34 may reflect poorly preserved antigenicity in the formalin-fixed specimen. 6, 17, 19 The primitive endoderm grows into the mesoderm to develop into the liver and the gallbladder in embryogenesis. 21 We speculate that progenitor cells in the gallbladder share some or all of the features of hepatic progenitor cells. Adults CK19: in IC cases-from 5 to 450% of the small cells (13/13 cases) Paraffin K Combined HC cases-in 5 to 450% of cells in transitional areas between the cholangiocytic and hepatocellular areas (6/6 cases) K Small cell HCC-5-50% positive in small cells in a few cases (3/10 cases) CK7: not carried out HepPar 1: IC cases À5 to 450% of small cells coexpressed with CK19 intensity (7/13 cases) K In CHC cases À5 to 10% strong in one case and 450% strong in the rest if the transitional areas expressed cholangiocytic and the hepatocyte markers (4/6 cases) K small cell HCC cases À5 to 450% of small cells (9/10 cases) CD117: 5 to 450% small cells in 6 tumors IC cases (10/13 cases) K 5-50% small cells within the transitional zone in combined HC cases (in 5/6 cases) K mostly 5% only in one case 50% small cells in small cell HCC cases (7/10 cases) and none of these cases expressed CK19 CEA: cytoplasmic expression in small cells ranging from 5 to 450% in 8/13 IC cases and 4/6 CHC cases, and none in small cell HCC cases To our knowledge, this is the first report of a primary gallbladder tumor comprising cells with the phenotype of hepatic progenitor/intermediate cells.
